PVLA Palvella Therapeutics Inc.

Price (delayed)

$149.56

Market cap

$2.15B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.83

Enterprise value

$1.97B

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 1
Highlights
The debt fell by 8% QoQ
Palvella Therapeutics's quick ratio has soared by 186% YoY but it has decreased by 27% from the previous quarter
The EPS has contracted by 16% from the previous quarter but it has grown by 11% YoY
The net income has dropped by 117% year-on-year and by 25% since the previous quarter
Palvella Therapeutics's equity has decreased by 7% QoQ

Key stats

What are the main financial stats of PVLA

PVLA stock price

How has the Palvella Therapeutics stock price performed over time
Intraday
-5.42%
1 week
-1.23%
1 month
5.29%
1 year
163.82%
YTD
42.89%
QTD
-2.13%

Financial performance

How have Palvella Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$57.74M
Net income
-$61.7M
Gross margin
N/A
Net margin
N/A
The net income has dropped by 117% year-on-year and by 25% since the previous quarter
The operating income has plunged by 117% YoY and by 27% from the previous quarter

Price vs fundamentals

How does PVLA's price correlate with its fundamentals

Growth

What is Palvella Therapeutics's growth rate over time

Valuation

What is Palvella Therapeutics stock price valuation
P/E
N/A
P/B
9.89
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has contracted by 16% from the previous quarter but it has grown by 11% YoY
PVLA's P/B is 61% above its 5-year quarterly average of 6.5 but 48% below its last 4 quarters average of 20.0
Palvella Therapeutics's equity has decreased by 7% QoQ

Efficiency

How efficient is Palvella Therapeutics business performance
PVLA's return on invested capital has surged by 61% since the previous quarter
PVLA's return on equity is up by 22% year-on-year and by 16% since the previous quarter
Palvella Therapeutics's ROA has increased by 10% YoY and by 10% from the previous quarter

Dividends

What is PVLA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PVLA.

Financial health

How did Palvella Therapeutics financials performed over time
Palvella Therapeutics's quick ratio has soared by 186% YoY but it has decreased by 27% from the previous quarter
PVLA's current ratio has soared by 176% year-on-year but it is down by 27% since the previous quarter
The debt is 100% lower than the equity
The debt fell by 8% QoQ
Palvella Therapeutics's equity has decreased by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.